Please assess the completion status of the following clinical trial:

Trial Title: Effects of InFat™ Product on Stool Biochemistry and Stool Characteristics in Formula-fed Term Chinese Infants

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Term infants: gestation 37-40 weeks~* Birth weight 2500-4000 g~* Apparent good health~* The infant is a product of normal pregnancy and delivery.~Exclusion Criteria:~* Any maternal disease (psychological or disabled) or socioeconomic problems that may interfere with the mother's ability to take care of her infant~* Major congenital abnormality or chromosomal disorder with a clinical significance that can be detected at birth, clinically significant~* Disease requiring mechanical ventilation or medication treatment at the first week (not including photo treatment for infantile hepatitis)~* Born with a 5- or 10-minute Apgar score \<7~* Any suspected or known metabolic or physical limitations interfering with feeding or normal metabolism (require a special formula)~* Breast-feeding for a week or over.~* Any other reason that, in the opinion of the investigator, prevents the subject from participating in the study.

- Gender: ALL
- Minimum Age: 1 Day
- Maximum Age: 8 Days
- Healthy Volunteers: t

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): Infant formula with InFat™ oil(containing \~49% of C16:0 at sn-2 position).
- 2 (Type: PLACEBO_COMPARATOR): Standard vegetable oil based infant formula

Based on this trial design, predict the completion outcome and termination type (if applicable).